Amerisource Health Services LLC recalls Haloperidol Decanoate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of assurance of sterility. Bacterial contamination detected in some media fill units
- Products
-
- Haloperidol Decanoate Injection
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 2,110 vials
- About this recall
- Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.